Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

Plain-English summary

Apollo Care, LLC is voluntarily recalling 56,918 vials of Semaglutide 12.5mg (2.5mg/mL), 5 mL sterile multi-dose vials. The recall was initiated because the product was found to contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.

The affected product is prescription-only and intended for subcutaneous injection. The recall covers specific lots with expiration dates ranging from November 17, 2026, to December 31, 2026. The product was distributed nationwide within the United States.

Consumers and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

The recalled product

Product

SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05

Manufacturer

Apollo Care, LLC

Category

Drug — Injectable Medication

Hazard

• particulate-matter

Affected units

56,918

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls